{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:19:39Z","timestamp":1794021579665,"version":"4.8.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 69-year-old man with intermediate-risk prostate cancer and a mildly elevated prostate-specific antigen of 8.2 \u03bcg\/L was referred for <jats:sup>68<\/jats:sup>Ga\u2013prostate-specific membrane antigen (<jats:sup>68<\/jats:sup>Ga-PSMA) PET\/CT for primary staging. An incidental intensely <jats:sup>68<\/jats:sup>Ga-PSMA\u2013avid hepatic focus was seen on PSMA PET and subsequent FDG PET\/CT and MRI cholangiogram. This was confirmed to be hepatocellular cholangiocarcinoma on subsequent histopathological examination.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003992","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T18:04:20Z","timestamp":1642010660000},"page":"e291-e293","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Incidental Intrahepatic Hepatocellular Cholangiocarcinoma Detected on 68Ga-PSMA PET\/CT"],"prefix":"10.1097","volume":"47","author":[{"given":"Christine","family":"Kang","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Yuheng","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Enoch","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET, Nepean Hospital, Kingswood"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Mansberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,12]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","article-title":"Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis","volume":"70","year":"2016","journal-title":"Eur Urol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"e204025","DOI":"10.1148\/rycan.2020204025","article-title":"High accuracy of PSMA PET in initial staging of high-risk prostate cancer","volume":"2","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","year":"2020","journal-title":"Cancer Imaging"},{"key":"bib4-20250621","first-page":"S13","article-title":"Overview of prostate-specific membrane antigen","volume":"6","year":"2004","journal-title":"Rev Urol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/wjnm.WJNM_78_19","article-title":"An overview on prostate-specific membrane antigen uptake in malignancies other than prostate cancer: a pictorial essay","volume":"19","year":"2020","journal-title":"World J Nucl Med"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"182","DOI":"10.18383\/j.tom.2018.00021","article-title":"Pitfalls in gallium-68 PSMA PET\/CT interpretation\u2014a pictorial review","volume":"4","year":"2018","journal-title":"Tomography"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.3748\/wjg.v26.i48.7664","article-title":"Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis","volume":"26","year":"2020","journal-title":"World J Gastroenterol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1097\/RLU.0000000000001771","article-title":"68Ga-PSMA uptake in combined hepatocellular cholangiocarcinoma with skeletal metastases","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib9-20250621","first-page":"136","article-title":"68Ga-prostate-specific membrane antigen, a potential radiopharmaceutical in PET\/CT to detect primary cholangiocarcinoma","volume":"8","year":"2020","journal-title":"Asia Ocean J Nucl Med Biol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:06:47Z","timestamp":1750536407000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,12]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003992","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,12]]}}}